Group 1 - CICC expects a net profit of 8.542 billion to 10.535 billion yuan for 2025, an increase of 50% to 85% year-on-year [1] - Huizhi Micro anticipates a net loss of 168 million to 235 million yuan for 2025, with revenue projected between 800 million to 860 million yuan [2] - Century Ruier forecasts a net profit of 44.8 million to 58 million yuan for 2025, representing a year-on-year increase of 31.1% to 69.73% [3] Group 2 - Huazi Industrial predicts a net profit of 58 million to 68 million yuan for 2025, an increase of 128% to 167% year-on-year [4] - Tianzhong Precision expects a net profit of 14 million to 17 million yuan for 2025, recovering from a loss of 154 million yuan in the previous year [5] - Meilixin anticipates a net loss of 455 million to 680 million yuan for 2025, compared to a loss of 164 million yuan in the previous year [6] Group 3 - Perfect World expects a net profit of 720 million to 760 million yuan for 2025, recovering from a loss of 1.288 billion yuan in the previous year [7] - Aerospace Hongtu forecasts a net loss of approximately 1.03 billion yuan for 2025 [8] - Tianma Zhikong anticipates a net profit of 84 million to 113 million yuan for 2025, a decrease of 66.61% to 75.26% year-on-year [9] Group 4 - Lianhuan Pharmaceutical received a drug registration certificate for lidocaine hydrochloride gel, which is used for local anesthesia [10] - Qiaoyin Co. won a sanitation and landscaping integrated service project worth 61 million yuan [11][12] - Kangtai Medical obtained a medical device registration certificate for a non-invasive ventilator [13] Group 5 - Wanhua Chemical plans to invest 19.086 billion yuan in its wholly-owned subsidiary Wanhua Olefins [14] - Zhongyuan New Materials expects a net profit of 52 million to 71 million yuan for 2025, a decrease of 44.22% to 59.15% year-on-year [15] - Taiji Group forecasts a net profit of 110 million yuan for 2025, an increase of approximately 313% year-on-year [16] Group 6 - Changjiang Securities expects a net profit of 3.695 billion to 3.668 billion yuan for 2025, an increase of 101.37% year-on-year [17] - Kanglongda anticipates a net profit of 80 million to 120 million yuan for 2025, recovering from a loss of 486 million yuan in the previous year [18] - Tainkang's subsidiary received a drug registration certificate for nimodipine injection [19] Group 7 - Kaiyin Technology forecasts a net profit of 26 million to 38 million yuan for 2025, a decrease of 73.31% to 81.74% year-on-year [20] - Xinyuren anticipates a net loss of 400 million to 480 million yuan for 2025 [21] - Aopumai expects a net profit of around 42 million yuan for 2025, an increase of 99.5% year-on-year [22] Group 8 - Zhaofeng Co. forecasts a net profit of 330 million to 370 million yuan for 2025, an increase of 136.26% to 164.89% year-on-year [23] - Aerospace Power anticipates a net loss of 178 million to 210 million yuan for 2025 [24] - Zhongwang Software expects a net profit of 16 million to 24 million yuan for 2025, a decrease of 62.48% to 74.99% year-on-year [25] Group 9 - Gansu Energy's wind power project has begun generating electricity, contributing to its renewable energy capacity [26] - Jinfeikeda has been selected as a designated supplier for an international automotive manufacturer [27] - Tibet Mining anticipates a net loss of 20 million to 40 million yuan for 2025, compared to a profit of 112 million yuan in the previous year [28] Group 10 - Haizheng Biomaterials expects a net profit of 750,000 to 950,000 yuan for 2025, a decrease of 73.24% to 78.88% year-on-year [29] - Shanwaishan forecasts a net profit of 140 million to 159 million yuan for 2025, an increase of 98% to 125% year-on-year [30] - Zhifei Biology's clinical trial application for a vaccine has been accepted [31][32] Group 11 - Zhengbang Technology anticipates a net loss of 470 million to 600 million yuan for 2025, compared to a profit of 216.4 million yuan in the previous year [33] - Pingmei Co. expects a net profit of 382 million to 432 million yuan for 2025, a decrease of 81.62% to 83.74% year-on-year [34] - Narui Radar forecasts a net profit of around 118 million yuan for 2025, an increase of 54.16% year-on-year [35] Group 12 - Western Gold anticipates a net profit of 425 million to 490 million yuan for 2025, an increase of 67.58% to 93.21% year-on-year [36] - Xinghui Entertainment expects a net profit of 270 million to 351 million yuan for 2025, recovering from a loss of 458 million yuan in the previous year [37] - Meiansen received an administrative regulatory decision from the Chongqing Securities Regulatory Bureau [38] Group 13 - Igor has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [39] - Yunyong Technology anticipates a net loss of 9.8 million to 14.7 million yuan for 2025, with a reduction in losses of 58.11% to 72.07% [40] - Sanwei Co. expects a net loss of 250 million to 380 million yuan for 2025, with losses expected to widen compared to the previous year [41] Group 14 - Greenland Holdings has recently secured 12 projects with a total value of 13.623 billion yuan [42] - Fuan Pharmaceutical's subsidiary received a drug registration certificate for a specific medication [43] - Chenyijia Intelligent has terminated its planned equity acquisition due to a lack of agreement on key terms [44] Group 15 - Yueneng Technology anticipates a net loss of 115 million to 140 million yuan for 2025 [45] - Sino Medical expects a net profit of 43 million to 50 million yuan for 2025, a significant increase year-on-year [46] - Dongwu Securities forecasts a net profit of 3.431 billion to 3.668 billion yuan for 2025, an increase of 45% to 55% year-on-year [47] Group 16 - Baoshui Technology anticipates a net loss of 80 million to 140 million yuan for 2025, with a significant reduction in net profit after excluding non-recurring gains and losses [48] - Aobi Zhongguang expects a net profit of around 123 million yuan for 2025, recovering from a loss of 62.9 million yuan in the previous year [49] - Tengda Construction's total bid amount for projects in 2025 is 1.536 billion yuan, a decrease of 16.55% year-on-year [50]

Core Viewpoint - The company Huizhiwei (688512.SH) expects to achieve an annual revenue of between 800 million to 860 million yuan in 2025, while projecting a net loss attributable to shareholders of the parent company between 235 million to 168 million yuan for the same year [1] Financial Performance - The company reported significant improvement in overall operating performance compared to the same period last year, with revenue growth and a reduction in the scale of losses [1] - The main reasons for the performance changes include continuous product structure optimization and successful mass production of the Phase8L fully integrated L-PAMiD product in leading domestic Android flagship models [1] - Revenue from overseas Android customers for products such as 5GMMMB and L-PAMiF has steadily increased, contributing to revenue growth [1] Cost Management and Profitability - The company improved gross profit levels by optimizing product structure and reducing procurement costs, leading to an increase in sales profit compared to the previous year [1] - Government subsidies related to revenue have increased year-on-year, while research and development expenses have decreased compared to the previous year [1] - These combined factors have resulted in a reduction in net losses compared to the same period last year [1]

Core Viewpoint - The company Huizhiwei (688512.SH) forecasts a net loss attributable to shareholders of the parent company for the year 2025, estimated between 168 million to 235 million yuan, despite significant improvements in operational performance compared to the previous year [1] Group 1: Financial Performance - The company expects a net loss of 168 million to 235 million yuan for 2025 [1] - The overall operating performance has significantly improved, with revenue increasing year-on-year and the scale of losses continuing to narrow [1] - The reduction in net loss compared to the previous year is attributed to an optimized product structure and increased government subsidies related to revenue [1] Group 2: Product Development and Market Expansion - The company has focused on upgrading products and expanding customer reach in the radio frequency front-end chip sector [1] - The Phase8L fully integrated L-PAMiD product has achieved mass production and shipment in leading domestic Android flagship models [1] - The company has seen steady growth in shipments of products like 5GMMMB and L-PAMiF to overseas Android customers, contributing to revenue growth [1] Group 3: Cost Management and Profitability - The company improved gross profit levels by optimizing product structure and reducing procurement costs [1] - Sales profit has increased compared to the previous year due to these improvements [1] - Research and development expenses have decreased compared to the previous year, further supporting financial performance [1]

Core Viewpoint - The company Huizhiwei (688512.SH) expects to achieve an annual revenue of between 800 million to 860 million yuan in 2025, while projecting a net loss attributable to shareholders of the parent company between 235 million to 168 million yuan for the same year [1] Financial Performance - The company reported significant improvement in overall operating performance compared to the same period last year, with revenue growth and a reduction in the scale of losses [1] - The main reasons for the performance changes include continuous product upgrades and customer expansion in the radio frequency front-end chip business [1] Product Development - The Phase8L fully integrated L-PAMiD product has achieved mass production and shipment in leading domestic Android flagship models, while products like 5GMMMB and L-PAMiF have seen steady shipment increases with overseas Android customers [1] - The optimization of product structure and reduction in procurement costs have improved gross profit levels, contributing to an increase in sales profit compared to the previous year [1] Government Support and R&D - The company has confirmed an increase in government subsidies related to revenue, while R&D expenses have decreased compared to the previous year [1] - These combined factors have led to a reduction in net losses compared to the same period last year [1]

Financial Projections - The company expects to achieve an annual revenue of between 800 million and 860 million yuan for 2025[4] - The projected net loss attributable to shareholders for 2025 is estimated to be between 235 million and 168 million yuan[4] - The net loss attributable to shareholders after deducting non-recurring gains and losses is expected to be between 330 million and 263 million yuan[4] Previous Year Performance - The previous year's revenue was 523.99 million yuan, with a net loss of 438.42 million yuan[6] - The company has improved its product structure, leading to a significant reduction in the scale of losses compared to the previous year[8] Product Development and Market Growth - The Phase8L integrated L-PAMiD product has achieved mass production and shipment in high-end flagship Android models in China[8] - The company has seen steady growth in shipments of 5G MMMB and L-PAMiF products to overseas Android customers[8] Financial Data and Risks - Government subsidies related to revenue have increased year-on-year, while R&D expenses have decreased compared to the previous year[8] - The company emphasizes that the financial data is preliminary and has not been audited by registered accountants[5] - Investors are advised to pay attention to investment risks as the data is subject to change in the official 2025 annual report[10]

Core Viewpoint - The company expects to achieve revenue of 800 to 860 million yuan in 2025, an increase from 524 million yuan in the same period last year, while narrowing its net loss significantly [1] Revenue and Profit Forecast - Projected revenue for 2025 is between 800 million and 860 million yuan, compared to 524 million yuan in the previous year [1] - The net profit attributable to the parent company is expected to be between -235 million and -168 million yuan, improving from -438 million yuan year-on-year [1] - The non-recurring net profit is forecasted to be between -330 million and -263 million yuan, compared to -474 million yuan in the same period last year [1] Factors Influencing Performance - The performance improvement is primarily attributed to product structure optimization and the mass production and shipment of the Phase8L product [1] - Increased shipments of 5GMMMB and L-PAMiF products have contributed to revenue growth [1] - Improvements in gross margin, increased government subsidies, and reduced R&D expenses have led to a narrowing of net losses [1]

Military and Geopolitical Developments - The US Central Command announced that the Ninth Air Force will conduct air force readiness exercises in the Middle East, aimed at enhancing rapid deployment capabilities [2] - The USS Abraham Lincoln Carrier Strike Group has entered the Middle East, and the US has informed Israel about military preparations against Iran, expected to be completed within two weeks [2] - Iran's Revolutionary Guard Navy officials stated they have achieved real-time monitoring of the Strait of Hormuz and are prepared for any potential conflict, asserting they do not seek war but are ready for a response [2] Financial Markets Overview - US stock markets showed mixed results, with the Dow Jones down 0.83%, while the Nasdaq rose by 0.91% and the S&P 500 increased by 0.41% [3] - Major tech stocks mostly rose, with Amazon up 2.63%, Microsoft up 2.19%, and Apple up 1.12%, while Tesla fell nearly 1% [3] - The Nasdaq Golden Dragon China Index increased by 0.48%, with mixed performances among popular Chinese stocks [3] Commodity Prices - International oil prices rose, with WTI crude oil futures closing at $62.57 per barrel, up 3.20%, and Brent crude oil futures at $66.70 per barrel, up 2.98% [3] - Spot gold increased by 3.45%, reaching $5,181.04 per ounce, with a peak at $5,190.06, marking a historical high [3] - Spot silver rose by 7.97%, priced at $112.14 per ounce [3] Currency and Exchange Rates - The US Dollar Index fell to 95.775, hitting a low of 95.510, the lowest since early 2022 [4] - The offshore RMB was quoted at 6.9321, while the onshore RMB was at 6.9545 [5] Corporate Announcements - Anta Sports announced plans to acquire a 29.06% stake in Puma for €15.06 billion (approximately 123 billion RMB), aiming to become its largest shareholder [15] - Micron Technology plans to invest $24 billion in Singapore over the next decade to expand NAND flash memory production, creating approximately 1,600 jobs [16] - DeepSeek launched a new AI model, DeepSeek-OCR 2, which can interpret images in a human-like logical sequence, enhancing its visual understanding capabilities [13]

Shareholder Reductions - Zhishang Technology's shareholders Liu Dongsheng and Liu Dongli plan to reduce their holdings by no more than 3% [1] - Hengtian Hailong's shareholder Hengtian Group intends to reduce its holdings by no more than 3% [1] - Shouchuang Securities' shareholder Chengshi Dongli plans to reduce its holdings by no more than 27.245 million A-shares [1] - Olin Bio's shareholder Taichang Group intends to reduce its holdings by no more than 6 million shares [1] - Juhe Materials' shareholder Changzhou Pengji plans to reduce its holdings by no more than 1.2297% [1] - Fuzhijie Technology's actual controller and its concerted actors plan to reduce their holdings by no more than 1% [1] - Sanjiang Shopping's shareholder Alizetai has reduced 6.1653 million shares through block trading [1] - Aonong Bio's shareholders including Foreign Trade Trust, Xiamen Trust, and Beijing Yawen plan to reduce their holdings by no more than 1% [1] - Dongfang Communication has cumulatively reduced 2.6 million shares of Changxin Bochuang [1] - XG Group has cumulatively reduced 473,900 shares [1] - Jiazhe New Energy's GLP has cumulatively reduced 1.08% of the company's shares [1] - Tuojing Technology's shareholder National Integrated Circuit Fund has cumulatively reduced 2.99% of its shares through block trading [1] - Huizhiwei's shareholder Great Fund Phase II has cumulatively reduced 0.57542% of the company's shares [1] Other Notable Events - ST Nachuan's stock trading may be subject to delisting risk warning [1] - Gao Meng New Materials' actual controller and vice chairman Xiong Haitao has been detained [1]

（文章来源：证券日报） 证券日报网讯 1月27日，慧智微发布公告称，国家集成电路产业投资基金二期股份有限公司于2026年1 月12日至1月27日通过集中竞价减持公司2，686，331股，占当前总股本0.57542%，减持后持股23， 342，117股，占总股本4.99999%，不再是持股5%以上股东。 ...

证券代码：688512 证券简称：慧智微 公告编号：2026-001 广州慧智微电子股份有限公司 重要内容提示： 一、本次权益变动基本情况 信息披露义务人本次权益变动系：一是通过上海证券交易所集中竞价减持其所持 有的公司股份，二是因公司股权激励行权导致总股本增加后持股比例被动稀释。具体 变动情况如下： （一）信息披露义务人基本情况 本次权益变动属于广州慧智微电子股份有限公司（以下简称"公司"）持股 5%以上股东国家集成电路产业投资基金二期股份有限公司（以下简称"大基 金二期"）实施已披露的股份减持计划及持有股份被动稀释，不触及要约收购。 股东大基金二期所持股份来源于IPO前取得。本次权益变动后，大基金二期持 有公司23,342,117股，占公司总股本的4.99999%，不再是公司持股5%以上的股 东。 本次权益变动为持股5%以上非第一大股东减持及被动稀释，不会导致公司控 股股东、实际控制人发生变化。 | 公司名称 | 国家集成电路产业投资基金二期股份有限公司 | | --- | --- | | 注册地址 | 北京市北京经济技术开发区景园北街2号52幢7层701-6 | | 法定代表人 张新 | | | 注册资 ...